AUTH/2936/2/17: Health professional consultant v Johnson & Johnson – Online Nicorette advertisement (No breach)

📅 2017 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2936/2/17
PartiesHealth professional consultant to a pharmaceutical company v Johnson & Johnson
ProductNicorette (nicotine)
MaterialOnline advertisement published in Pulse magazine (February); ref UK/NI/16-7093(1)
Main claims challenged“Combination NRT is 43% more effective than patch alone”; “nothing beats Nicorette dual support”; headline “How do you empower them to quit for good?”
Main issuesAlleged lack of absolute data; alleged implication of guaranteed success; imagery of an infant
Code year2016
Clauses consideredClause 7.2; Clause 9.1
Panel decisionNo breach
Complaint received15 February 2017
Case completed27 April 2017
AppealNo appeal
SanctionsNone stated

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A health professional (consultant to a pharmaceutical company) complained in a private capacity about an online Nicorette (nicotine) advertisement by Johnson & Johnson, published in Pulse (February).
  • The ad headline: “How do you empower them to quit for good?” and included claims: “Combination NRT is 43% more effective than patch alone” and “nothing beats Nicorette dual support”.
  • The ad showed Nicorette patch and Nicorette QuickMist mouth spray, plus a lifestyle image of an adult throwing/catching an infant on a beach.
  • Allegations: (1) the child pictured was an inappropriate age; (2) the “43% more effective” claim gave no absolute data; (3) the headline could imply quitting “for good” always works.
  • PMCPA correspondence drew attention to Clauses 7.2 and 9.1.
⚖️

Outcome

  • No breach of Clause 7.2.
  • No breach of Clause 9.1.
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training